Physician

Venkata V Bavikati, MBBS, MPH

According to 2025 Medicare claims, Venkata Bavikati, MBBS, MPH (NPI: 1538346796) practices cardiac electrophysiology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is TALLAHASSEE MEMORIAL HEALTHCARE INC (NPI: 1366293102; TIN: 591917016) and primary practice location at 32308-5054. Bavikati is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Bavikati's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,359 traditional Medicare patients, billed 5,485 HCPCS/CPT codes, and received $336,175 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,815 prescription claims across 1,020 beneficiaries totaling $2,379,426 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 19 claims. Open Payments data shows 42 records totaling $3,262. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $147,413 to $336,175. Similarly, Part D prescription costs have moved sharply higher in recent years, from $29,249 to $2,379,426. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	500	1,523	$147,413
2016	562	2,332	$211,811
2017	704	3,030	$247,564
2018	866	3,676	$293,409
2019	1,511	5,369	$375,507
2020	1,425	5,182	$315,794
2021	1,352	5,740	$365,498
2022	1,312	5,157	$314,931
2023	1,455	5,886	$334,018
2024	1,359	5,485	$336,175

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	104	373	$29,249
2016	225	1,365	$157,734
2017	326	2,460	$345,758
2018	471	3,435	$570,306
2019	639	4,464	$924,909
2020	712	5,320	$1,337,862
2021	822	5,725	$1,575,359
2022	910	5,976	$1,814,730
2023	1,034	6,403	$2,227,142
2024	1,020	6,815	$2,379,426

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	12	$25,276
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	19	$45,292
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	213	218	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	316	360	$92
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	278	910	$23
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	290	339	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	453	563	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	2,405	97,421	$1,836,769
Xarelto	Rivaroxaban	279	13,501	$239,221
Entresto	Sacubitril/Valsartan	117	4,444	$93,303
Farxiga	Dapagliflozin Propanediol	102	4,080	$70,570
Dofetilide	Dofetilide	223	9,718	$30,365

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$1,342	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$1,920	Impulse Dynamics (USA) Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Venkata V. Bavikati, MBBS, MPH?

Tedicare shows public-source Medicare data for Venkata V. Bavikati, MBBS, MPH (NPI 1538346796), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Venkata V. Bavikati, MBBS, MPH have ACO affiliation data?

Venkata V. Bavikati, MBBS, MPH is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Venkata V. Bavikati, MBBS, MPH?

Venkata V. Bavikati, MBBS, MPH is linked to TALLAHASSEE MEMORIAL HEALTHCARE INC (billing NPI 1366293102) in the available physician profile data.

Does Venkata V. Bavikati, MBBS, MPH have Open Payments data?

Venkata V. Bavikati, MBBS, MPH has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.